The cancer-associated Sm-like (CaSm) oncogene is overexpressed in 87% of human pancreatic tumor samples and CaSm knockdown has demonstrated therapeutic efficacy in murine models of pancreatic cancer. cancer that has had few new therapies developed in the past decade. Beyond the LSm1 correlates relatively little remains known about the role for CaSm in the process… Continue reading The cancer-associated Sm-like (CaSm) oncogene is overexpressed in 87% of human